Publication | Open Access
Phase 1 study of C-CAR088, a novel humanized anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma
31
Citations
24
References
2022
Year
NCT03815383, NCT03751293, NCT04295018, and NCT04322292.
| Year | Citations | |
|---|---|---|
Page 1
Page 1